Stock CGEN COMPUGEN LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Compugen Ltd.

Equities

CGEN

IL0010852080

Real-time Estimate Cboe BZX
Other stock markets
 02:50:18 2024-05-15 pm EDT 		5-day change 1st Jan Change
2.205 USD +5.50% Intraday chart for Compugen Ltd. +2.35% +10.10%
04:04pm Compugen Names David Silberman CFO MT
Mar. 08 Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Compugen Names David Silberman CFO
MT
Compugen Appoints David Silberman as Chief Financial Officer
PR
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
PR
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
AQ
Compugen : To Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
PU
Compugen to Participate in Two Upcoming Investor Conferences
PR
Compugen : Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy
PU
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy
PR
Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating
MT
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024
AQ
Compugen : To Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024
PU
Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024
Compugen: Q4 Earnings Snapshot
AQ
Earnings Flash (CGEN) COMPUGEN Reports Q4 Revenue $33.5M
MT
Earnings Flash (CGEN) COMPUGEN Posts Q4 EPS $0.11
MT
Compugen : Form 6-K- Fourth quarter and full year 2023 results
PU
Earnings Flash (CW9) COMPUGEN Posts Q4 EPS $0.11
MT
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Compugen Reports Fourth Quarter and Full Year 2023 Results
PR
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGEN Stock
  4. News Compugen Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW